Free Trial

Elevai Labs Q2 2023 Earnings Report

Elevai Labs logo
$1.18 -0.04 (-2.89%)
As of 02:02 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Elevai Labs EPS Results

Actual EPS
-$26.00
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Elevai Labs Revenue Results

Actual Revenue
$0.32 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Elevai Labs Announcement Details

Quarter
Q2 2023
Time
N/A

Conference Call Resources

Elevai Labs Earnings Headlines

Elevai Labs, Inc. (NASDAQ:ELAB) Short Interest Down 44.6% in February
$2 Trillion Disappears Because of Fed's Secretive New Move
$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being carried out by the Fed that has nothing to do with lowering or raising interest rates... but could soon have an enormous impact on your wealth.
Analyzing Elevai Labs (NASDAQ:ELAB) and Inventiva (NASDAQ:IVA)
PMGC files to sell 969,386 shares of common stock for holders
See More Elevai Labs Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Elevai Labs? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Elevai Labs and other key companies, straight to your email.

About Elevai Labs

Elevai Labs (NASDAQ:ELAB), a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc. and changed its name to Elevai Labs, Inc. in December 2021. Elevai Labs, Inc. was incorporated in 2020 and is based in Newport Beach, California.

View Elevai Labs Profile

More Earnings Resources from MarketBeat